Healthcare IT News November 8, 2021
Mike Miliard

The new document, published this past week, takes stock of a fast-changing technology environment – and would replace the agency’s previous medical device guidance, first issued more than 16 years ago.

This past week, the U.S. Food and Drug Administration published draft guidance for its Content of Premarket Submissions for Device Software Functions.

The guidance, posted online on November 4, intended to provide information regarding the recommended documentation to include in premarket submissions for the FDA to evaluate the safety and effectiveness of device software functions.

The FDA’s draft recommendations pertain to device software functions – software in a medical device (SiMD) and software as a medical device (SaMD), most notably – and describe data that would be generated...

Today's Sponsors

Patient Bond
Institute for Healthcare Improvement

Today's Sponsors

Oliver Wyman
Patient Bond

Today's Sponsor

Patient Bond

Topics: FDA, Govt Agencies, Medical Devices
A biotech wins the first FDA drug approval in a rare type of eye cancer
Big Health’s Softbank Money, FDA Board Member Send Strong Signals About Digital Therapeutics Market
Will FDA and DOJ Reassert Their Enforcement Muscle With Life Sciences in 2022?
Neurological devices, diagnostics dominate latest FDA breakthrough designations
5 questions facing the FDA in 2022